COURTNEY MISHLER: Open Payments
NPI 1114381449 · SEAFORD, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$716 in 34 payments from 19 companies in 2025. Trend: 2023 $98 · 2024 $121 · 2025 $716
Food & beverage: $716
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $86 |
| Lilly USA, LLC | 4 | $73 |
| Phathom Pharmaceuticals, Inc. | 3 | $65 |
| AstraZeneca Pharmaceuticals LP | 2 | $60 |
| Sumitomo Pharma America, Inc. | 2 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $48 |
| Exact Sciences Corporation | 2 | $39 |
| Amgen Inc. | 2 | $39 |
| PFIZER INC. | 2 | $39 |
| Aimmune Therapeutics, Inc. | 1 | $35 |
Products named: UBRELVY, VOQUEZNA, AIRSUPRA, MOUNJARO, GEMTESA, XIFAXAN, Cologuard Collection Kit, OTEZLA.
Industry payments across DE — which companies pay providers there.
